Elsevier

Neurologic Clinics

Volume 22, Issue 3, August 2004, Pages 591-617
Neurologic Clinics

Review article
Cardiac function tests in neuromuscular diseases

https://doi.org/10.1016/j.ncl.2004.03.001Get rights and content

Section snippets

Neuromuscular diseases with cardiac involvement

The symptoms caused by cardiac disease in neuromuscular disorders depend on the type and severity of involvement and the degree of skeletal muscle disability. In Duchenne and Becker muscular dystrophies, abnormal amounts of dystrophin in cardiac myocytes lead to their necrosis and fibrosis with resultant cardiomyopathy [1], [2], [3], [4]. Symptoms of congestive heart failure, such as dyspnea, fatigue, orthopnea, and edema, are seen with varying frequency. The development of symptoms is

The cardiac physical examination

Cardiac physical examination findings in neuromuscular diseases are not specific to any one disorder. The presence of abnormal examination findings can be the first indication of underlying cardiac involvement and can serve as a clue to the type of involvement. Cannon (amplified) a-waves in the jugular venous pulse suggest dissociation of atrial and ventricular contraction and can be seen with complete heart block, whereas loss of a-waves is seen with atrial fibrillation or standstill. During

Electrocardiography

The ECG is a universally available and commonly used screening test in cardiology (Fig. 1). The resting 12-lead ECG is a useful tool for determining if cardiac involvement is present and often suggests the severity of such involvement in the majority of neuromuscular diseases. It is able to assess noninvasively the underlying cardiac rhythm, the integrity of AV conduction and intraventricular conduction, the presence of transient, ectopic beats and rhythms, and chamber enlargement. Ambulatory

Cardiac imaging studies

Imaging studies provide a noninvasive, detailed evaluation of cardiac function. Radiographic studies, such as radionuclide angiography, are able to assess ventricular size, function, wall motion, and myocardial perfusion. Cardiac ultrasonography, or echocardiography, also can estimate ventricular function but, in addition, can quantitatively assess atrial and ventricular dimensions and myocardial wall thickness, detect regional wall motion abnormalities resulting from areas of myocardial

Electrophysiologic testing

Invasive electrophysiologic (EP) testing provides a detailed evaluation of intracardiac conduction and assesses the risk and potential for arrhythmias. Many of the neuromuscular diseases manifest their cardiac involvement primarily with arrhythmias. Precise anatomic location of the site of conduction delay or block can be determined using specialized intracardiac catheters capable of measuring and delivering electrical stimuli. In general, conduction abnormalities within the AV node typically

Management of cardiac involvement

Diagnostic evaluation and therapy for cardiac involvement resulting from neuromuscular diseases should be aimed at determining the type and degree of involvement, limiting progression of underlying cardiac dysfunction, treating symptoms of congestive heart failure, and preventing complications from rhythm disturbances, such as bradycardia and tachycardia, mainly through device implantation. Despite the paucity of evidence regarding management of cardiac involvement in these disorders,

Neurology referral to cardiology

The timing of cardiology referral should be based on the presence of cardiac involvement and symptoms. Patients who have one of the neuromuscular diseases and an abnormal ECG should be referred to a cardiologist for further evaluation, even in the absence of cardiac symptoms. Those who have imaging abnormalities, such as LV dilatation, dysfunction, or regional wall motion abnormalities, also should be referred. The occurrence of symptoms as a result of congestive heart failure (dyspnea,

First page preview

First page preview
Click to open first page preview

References (54)

  • L Badano et al.

    Left ventricular myocardial function in myotonic dystrophy

    Am J Cardiol

    (1993)
  • J.S Child et al.

    Myocardial myotonia in myotonic muscular dystrophy

    Am Heart J

    (1995)
  • R Ortiz-Lopez et al.

    Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy

    Circulation

    (1997)
  • R.R Kaprielian et al.

    Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium

    Circulation

    (2000)
  • C Stollberger et al.

    Progression of cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy during a 2-year follow-up

    Cardiology

    (1998)
  • P Melacini et al.

    Heart involvement in muscular dystrophies due to sarcoglycan mutations

    Muscle Nerve

    (1999)
  • A.J van der Kooi et al.

    A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement

    Ann Neurol

    (1996)
  • W.J Groh et al.

    Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length

    J Cardiovasc Electrophysiol

    (2002)
  • P Melacini et al.

    Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy

    Circulation

    (1996)
  • P Laforet et al.

    Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy

    Neurology

    (1998)
  • A Lazarus et al.

    Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy

    Circulation

    (1999)
  • G Nigro et al.

    Evaluation of the cardiomyopathy in Becker muscular dystrophy

    Muscle Nerve

    (1995)
  • A Nagano et al.

    Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy

    Nat Genet

    (1996)
  • G.E Morris et al.

    Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy

    Hum Mol Genet

    (1999)
  • A.J van der Kooi et al.

    Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy

    Neurology

    (2002)
  • G.L Brodsky et al.

    Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement

    Circulation

    (2000)
  • D Fatkin et al.

    Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

    N Engl J Med

    (1999)
  • Cited by (4)

    • Neurology and cardiology: Points of contact

      2011, Revista Espanola de Cardiologia
    • Skeletal muscle involvement in cardiomyopathies

      2013, Journal of Cardiovascular Medicine
    • The heart in muscular dystrophy

      2005, Pediatric Annals
    View full text